Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?

Abstract

The term vasospasm is commonly used to describe constriction of cerebral blood vessels after subarachnoid hemorrhage which results in the restriction of blood flow and ischemia in affected portions of the brain. The pathophysiological changes that underlie vascular constriction after subarachnoid hemorrhage include changes within the vessel walls themselves, alteration of the levels of several vasoactive substances, and broader pathological conditions such as immune responses, inflammation, and oxidative damage. In this review, we summarize the current state of knowledge concerning the processes that occur in cerebral blood vessels after subarachnoid hemorrhage and how they may be involved in the development of vasospasm. We also propose that, rather than merely vasospasm, the multitude of vascular effects occurring after subarachnoid hemorrhage can be best described as a post-subarachnoid hemorrhage vasculopathy.

Keywords

acute vasospasm delayed vasospasm subarachnoid hemorrhage vasculopathy

References

Oyama K. , Criddle L. Vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Nurse 2004; 24: 58—67.

Harrod CG , Bendok BR , Batjer HH Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 2005; 56: 633—54.

Treggiari-Venzi MM , Suter PM , Romand JA Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care . Neurosurgery 2001; 48: 249—61.

Ohkuma H. , Itoh K. , Shibata S. , Suzuki S. Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs. Neurosurgery 1997; 41: 230—35.

Nakamura S. , Tsubokawa T. , Yoshida K. , Hirasawa T. , Nakano M. Appearance of collagen fibers in the cerebral vascular wall following subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1992; 32: 877—82.

Conway LW , McDonald LW Structural changes of the intradural arteries following subarachnoid hemorrhage . J Neurosurg 1972; 37: 715—23.

Hughes JT , Schianchi PM Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978; 48: 515—25.

Gules I. , Satoh M. , Clower BR , Nanda A. , Zhang JH Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol 2002; 283: H2551—59.

Zubkov AY , Tibbs RE , Clower B. , Ogihara K. , Aoki K. , Zhang JH Morphological changes of cerebral arteries in a canine double hemorrhage model . Neurosci Lett 2002; 326: 137—41.

10.

Zhou C. , Yamaguchi M. , Kusaka G. , Schonholz C. , Nanda A. , Zhang JH Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24: 419—31.

11.

Iuliano BA , Pluta RM , Jung C. , Oldfield EH Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg 2004; 100: 287—94.

12.

Alkan T. , Tureyen K. , Ulutas M. et al. Acute and delayed vasoconstriction after subarachnoid hemorrhage: local cerebral blood flow, histopathology, and morphology in the rat basilar artery. Arch Physiol Biochem 2001; 109: 145—53.

13.

Pradilla G. , Wang PP , Legnani FG , Ogata L. , Dietsch GN , Tamargo RJ Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg 2004; 101: 88—92.

14.

Nam DH , Kim JS , Hong SC et al. Expression of interleukin-1 beta in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neurosci Lett 2001; 312: 41—44.

15.

McGirt MJ , Mavropoulos JC , McGirt LY et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98: 1222—26.

16.

Phillis JW , O'Regan MH. The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries. Crit Rev Neurobiol 2003; 15: 61—90.

17.

Osuka K. , Suzuki Y. , Watanabe Y. , Takayasu M. , Yoshida J. Inducible cyclooxygenase expression in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 1998; 29: 1219—22.

18.

Shimizu T. , Watanabe T. , Asano T. , Seyama Y. , Takakura K. Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoidal hemorrhage. J Neurochem 1988; 51: 1126—31.

19.

Barbosa MD , Arthur AS , Louis RH et al. The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Neurosurgery 2001; 49: 1205—12.

20.

Watanabe T. , Asano T. , Shimizu T. , Seyama Y. , Takakura K. Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem 1988; 50: 1145—50.

21.

Hirashima Y. , Endo S. , Kurimoto M. , Tsukamoto E. , Takaku A. Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. Acta Neurochir (Wien) 1994; 128: 144—49.

22.

Hirashima Y. , Endo S. , Kato R. , Takaku A. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880 . J Neurosurg 1996; 84: 826—30.

23.

Satoh M. , Date I. , Nakajima M. et al. Inhibition of poly(ADPribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 2001; 32: 225—31.

24.

Hongo K. , Kassell NF , Nakagomi T. et al. Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 1988; 69: 247—53.

25.

Cardillo C. , Kilcoyne CM , Cannon RO 3rd, Panza JA. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000; 35: 1237—41.

26.

Wang X. , Zhu C. , Zhang G. , Lu Y. Changes of endothelin during cerebral vasospasm after experimental subarachnoid hemorrhage. Chin Med J (Engl) 1995; 108: 586—90.

27.

Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage . J Neurosurg 2000; 92: 390—400.

28.

Pluta RM , Afshar JK , Boock RJ , Oldfield EH Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg 1998; 88: 557—61.

29.

Gabikian P. , Clatterbuck RE , Eberhart CG , Tyler BM , Tierney TS , Tamargo RJ Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke 2002; 33: 2681—86.

30.

Thomas JE , Rosenwasser RH Reversal of severe cerebral vasospasm in three patients after aneurismal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 1999 ; 44: 48—57.

31.

Kawanabe Y. , Masaki T. , Hashimoto N. Effects of the Ca++permeable nonselective cation channel blocker LOE 908 on subarachnoid hemorrhage-induced vasospasm in the basilar artery in rabbits . J Neurosurg 2003; 98: 561—64.

32.

Ono S. , Komuro T. , Macdonald RL Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 2002; 96: 1094—102.

33.

Horky LL , Pluta RM , Boock RJ , Oldfield EH Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 1998; 88: 298—303.

34.

Shibata S. , Suzuki S. , Ohkuma H. , Kimura M. , Fujita S. Effects of intracisternal methylprednisolone on lipid peroxidation in experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 1999; 141: 529—32.

35.

Mori T. , Nagata K. , Town T. , Tan J. , Matsui T. , Asano T. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 2001; 32: 636—42.

36.

Kamii H. , Kato I. , Kinouchi H. et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 1999; 30: 867—71.

37.

Kassell NF , Haley EC Jr , Apperson-Hansen C. , Alves WM Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 1996 ; 84: 221—28.

38.

Haley EC Jr , Kassell NF , Apperson-Hansen C. , Maile MH , Alves WM A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 1997; 86: 467—74.

39.

Lanzino G. , Kassell NF , Dorsch NW et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa . J Neurosurg 1999; 90: 1011—17.

40.

Lanzino G. , Kassell NF Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 1999; 90: 1018—24.

41.

Pickard JD , Murray GD , Illingworth R. et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989; 298: 636—42.

42.

Hui C. , Lau KP Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 2005; 60: 1030—36.

43.

Rinkel GJ , Feigin VL , Algra A. , van den Bergh WM , Vermeulen M. , van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005; 1: CD000277.

44.

Feng L. , Fitzsimmons BF , Young WL et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 2002; 23: 1284—90.

45.

Mazumdar A. , Rivet DJ , Derdeyn CP , Cross DT 3rd, Moran CJ. Effect of intraarterial verapamil on the diameter of vasospastic intracranial arteries in patients with cerebral vasospasm. Neurosurg Focus 2006; 21: E15.

46.

Wilson SR , Hirsch NP , Appleby I. Management of subarachnoid haemorrhage in a non-neurosurgical centre. Anaesthesia 2005; 60: 470—85.

47.

Awad IA , Carter LP , Spetzler RF , Medina M. , Williams FC Jr.Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18: 365—72.

48.

Lee KH , Lukovits T. , Friedman JA `Triple-H' therapy for cerebral vasospasm following subarachnoid hemorrhage . Neurocrit Care 2006; 4: 68—76.

49.

Bejjani GK , Bank WO , Olan WJ , Sekhar LN The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998; 42: 979—86.

50.

Polin RS , Coenen VA , Hansen CA et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000; 92: 284—90.

51.

Liu JK , Couldwell WT Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care 2005; 2: 124—32.

52.

Ram Z. , Sadeh M. , Shacked I. , Sahar A. , Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22: 922—27.

53.

Van den Bergh WM , Algra A. , van Kooten F. et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005; 36: 1011—15.

54.

Van den Bergh WM , Dijkhuizen RM , Rinkel GJ Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 2004; 17: 301—13.

55.

Vaughan CJ , Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30: 1969—73.

56.

Tseng MY , Czosnyka M. , Richards H. , Pickard JD , Kirkpatrick PJ Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627—32.

57.

Mayberg MR , Batjer HH , Dacey R. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 2315—28.